APOD and breast cancer: Interestingly, there is no report of IL33 as a prognostic marker of BC, but consistency of our findings regarding CXCL14, LIFR, and APOD with previous studies indicates our method to be reliable, and thus supports the reliability of our conclusions to a large extent.